The global antipsychotic drug market size is expected to expand at a considerable CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increase in incidences of psychotic disorders such as hallucinations, schizophrenia, bipolar disorder, delusions, and severe depression.

1. QUICK LINKS
About Us
Faq
Press Release
My account
Blog
Contact Us
How to order
Refund and Cancellation
Become A Reseller
POPULAR CATEGORIES
Aerospace & Defense
Consumer Goods
Energy & Power
Healthcare
ICT, Semiconductor & Electronics
Materials & Chemicals
CONTACTS
1st Floor, Kalpavruksha O ce No 1,
GK Lane Number 3, Ingawale Nagar,
Pimple Nilakh, Pune, Maharashtra
411027

+1 909 414 1393

sales@growthmarketreports.com

KEEP IN TOUCH
CONNECT WITH US
WE ACCEPT
Your email 
Terms and conditions | Privacy | Growth Market Reports is Product of YOAAP Media Services LLP.
Home  Medical Devices & Supplies  Antipsychotic Drugs Market - Global Industry Analysis, Size, Share, Growth , Trends, and Forecast 2021 - 2028
An psycho c Drugs Market
Global Industry Analysis,
Size, Share, Growth , Trends,
and Forecast 2021 - 2028
Antipsychotic Drugs Market by Drugs Class (First Generation [Haldo, Navane,
and Others], Second Generation [Invega, Latuda, Seroquel, Risperdal,
Zyprexa, Geodon, and Others], Third Generation [Abilify]), Applications
(Schizophrenia, Bipolar Disorders, Dementia, Unipolar Depression, and
Others), and Regions (Asia Paci c, North America, Latin America, Europe,
and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size,
Trends, and Forecast 2021 – 2028.
Report ID: HC-2319
Author: Growth Market Reports
Rating: 4.9
Total Reviews: 3
No. Of Pages: 194
Format:  
Pub. Date: Upcoming
Share:   
Report Description Table Of Content Segments Competitive Landscape Methodology
The global antipsychotic drug market size is expected to expand at a considerable CAGR during the forecast period, 2021–2028. The
growth of the market is attributed to the increase in incidences of psychotic disorders such as hallucinations, schizophrenia, bipolar
disorder, delusions, and severe depression.
2018
H
2019
H
2020
A
2021
P
2022
P
2023
P
2024
P
2025
P
2026
P
2027
P
2028
P
-
200.0
400.0
600.0
800.0
1,000.0
1,200.0
1,400.0
1,600.0
1,800.0
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
XXXXX
XXXXX
XX%
XX% XX%
XX%
XX% XX%
XX%
XX%
XX%
XX%
Market Value Y-o-Y Growth
2020 2021 2022 2023 2024 2025 2026 2027 2028
XXXXX
XXXXX
XX
XX
XX
XX
XX
XX
XX
Market Value Abolute $ Opportunity
An psycho c Drugs Market Size (USD Million), Forecast
and Y-o-Y Growth, 2018-2028
An psycho c Drugs Market ,Absolute $ Opportunity, in
USD Million, 2020-2028
• Le Figure represents Antipsychotic Drugs Market size and forecast from 2018 to 2028; wherein 2018, 2019 are historic years, 2020 is the
base/actual year and forecast is provided from 2021 to 2028. The market is expected to grow at year-on-year growth rate of XX% between
2019 and 2020 owing to Covid-19 situa on and slowdown in the economic ac vi es.
• Right Figure represents the absolute $ opportunity between 2020 to 2028 in Antipsychotic Drugs Market . It indicates the availability of
poten al revenue generation opportunity for each year. The overall incremental opportunity between 2020 and 2028 is expected to be
valued at USD XX Mn.
Key Takeaways
Source: Growth Market Reports Analysis Source: Growth Market Reports Analysis
Antipsychotic drugs, also known as neuroleptics tranquilizers, are predominantly used for the treatment of psychosis and psychotic
diseases such as delusions, hallucinations, schizophrenia, bipolar disorder and others. Schizophrenia is considered to be the most
common and major psychotic disorder, which has a large number of patients across the globe. As per a study by the Anxiety and
Depression Association of America, anxiety is the most common mental illness in the US, around 40 million cases in the country were
recorded for the group of age 18 and above, or 18.1% of the population per year. Approximately one-half of the total number of
patients identi ed with depression are also detected with an anxiety disorder. The World Health Organization (WHO) has suggested
about the formulation of mental health action plan to prevent mental disorders and encourage mental health globally. Furthermore, as
per the statistics by WHO, an about 300 million people are suffering from depression whereas 60 million cases are diagnosed with
bipolar disorder globally. Children and adults are at high risk of psychiatric illnesses. It is estimated that nearly 44 million American
adults suffer from the ill-effects of uneasiness issue.
The COVID-19 pandemic caused several hardship in the global economy, due to the lockdowns and restriction imposed by the
governments across the globe. The pandemic had caused negative impact on the market due to large disruption in the production of
the drugs and delayed the non-COVID-19 emergency services. However, with the reduced number of the COVID-19 cases, the market
has regained its revenue due to wide resumption of the business operations worldwide.
Market Trends, Drivers, Restraints, and Opportunities
Heavy investments from key drugs manufacturing organizations for the development of effective drug as well as governments’
initiative to increase the awareness regarding the disorders among the population are driving the market in the near future.
Change in daily habits, increased consumption of drugs and alcohol, as well as rising stress life are key reasons for increasing
the mental issues among a large number of the global population. This is expected to drive the market growth.
Expansion of R&D activities and rapid introduction of novel antipsychotic compounds are bolstering the market growth.
Adverse effects such as blurred vision, insomnia, drowsiness, dry mouth, and probability of habit formation are proved to be
harmful for the patient’s health. These factors are hampering the market development in the coming years.
Rising patent terminations of key brands such as Risperdal, Seroquel, Invega, and Zyprexa, are restricting the market growth.
The presence of huge pool of geriatric population who are at high risk of psychosis and rising healthcare awareness are
projected to create huge opportunities for the market expansion during the forecast period.
Scope of the Report
The report on the global antipsychotic drugs market includes an assessment of the market, trends, segments, and regional markets.
Overview and dynamics have also been included in the report.
Attributes Details
Report Title Antipsychotic Drugs Market - Global
Industry Analysis, Growth, Share, Size,
Trends, and Forecast
Base Year 2020
Historic Data 2018–2019
Forecast Period 2021–2028
Segmentation Drugs Class (First Generation [Haldo,
Navane, and Others], Second Generation
[Invega, Latuda, Seroquel, Risperdal,
Zyprexa, Geodon, and Others], Third
Generation [Abilify]), and Applications
(Schizophrenia, Bipolar Disorders,
Dementia, Unipolar Depression, and
Others)
Regional Scope Asia Paci c, North America, Latin
America, Europe, and Middle East &
Africa
Report Coverage Company Share, Market Analysis and
Size, Competitive Landscape, Growth
Factors, and Trends, and Revenue
Forecast
Key Players Covered in the Report Johnson & Johnson; P zer, Inc.; Eli Lilly &
Co.; Bristol-Myers Squibb; AstraZeneca;
Glaxo SmithKline, Plc; and Allergan, Inc.
Market Segment Insights
Second generation segment is expected to grow at a rapid pace
Based on drugs class, the global antipsychotic drugs market is divided into rst generation, second generation, and third generation.
The rst generation segment is further classi ed into navane, haldo, and others. The second generation segment is segmented into
geodon, invega, latuda, zyprexa, seroquel, risperdal, and others while the third generation consists of abilify. The second generation
segment is expected to grow at a rapid pace attributed to the high e cacy of the drugs and are more advanced products than the
rst generation antipsychotics. This class is named as atypical antipsychotics includes sertindole, clozapine, asenapne, paliperidone,
olanzapine, risperidone, quetiapine. Meanwhile, the third generation segment is projected to account for a key market share since the
drugs are widely used for the maintenance therapy of the disease. Moreover, the drugs generation offer several bene ts such as
better tolerability and safety, which is contributing to the growth of the segment during the projected period.
An psycho c Drugs Market Basis Point Share (BPS) Analysis, by type
Source: Growth Market Reports Analysis
2021 2028
XX% XX%
XX% XX%
First Genera on Second Genera on Third Genera on
XX
XX
XX
Schizophrenia segment is projected to expand at a considerable CAGR
On the basis of applications, the market is segregated into schizophrenia, bipolar disorders, dementia, unipolar depression, and
others. The schizophrenia segment is projected to expand at a considerable CAGR owing to the high number of cases across the
world. Additionally, improved diagnostics & treatment and high awareness among the population is contributing for the fast growth
rate in the near future. Meanwhile, the unipolar disorder segment is anticipated to ourish remarkably in the near future due to the
easy diagnosis and increased awareness among the people. Moreover, the wide prevalence of the disorder globally is likely to drive the
segment growth.
North America is anticipated to constitute a key market share
In terms of regions, the global antipsychotic drugs market is classi ed as Asia Paci c, North America, Latin America, Europe, and
Middle East & Africa. North America is anticipated to constitute a key market share during the projected period as the region records
high number of mental illness patients. As per the report of Anxiety and Depression Association of America in year 2016,
approximately 6.7% population of the U.S. with age 18 years and more was suffering from major depression. Such high prevalence of
the disorder and improved healthcare services system in the region is anticipated to push the overall market growth.
Growth Poten al
CAGR
2020
-
27
Asia Pacific, XX
Middle East & Africa,
XX
North America, XX
La n America, XX
Europe, XX
Source: Growth Market Reports Analysis
An psycho c Drugs Market A rac veness Analysis by Regions
The Asia Paci c market, however, is estimated to grow at a signi cant rate in the coming years due to large number of the disorder
cases, developing healthcare facilities, and developing new drug approvals in the region. Additionally, the increasing awareness
among the population is also a key factor for the market growth in the region.
Customize This Report
Ask for Research To Be Focused On
Speci c Regions or Segments
Receive Data As Per Your Format and
De nition
Companies Pro led based on Your
Requirements
Breaking Down Competitive
Landscape as per Your Requirements
Any Level of Customization
Our Clients
Client Testinomials
Get in Touch with Us
 +1 909 414 1393
 sales@growthmarketreports.com
Buy Report
Single User $4200 
Multi User $5200 
Corporate User $6600 
Online License $2999 
Excel Data Pack $2599 
Add to Cart
REQUEST FOR SAMPLE
ENQUIRY BEFORE BUYING
SPEAK WITH ANALYST
REQUEST FOR CUSTOMIZATION
 
We needed a highly accurate and
precise report, which Growth Market
Reports delivered promptly. The
company compiled information from a
wide array of reliable agencies and
sourcess.It is extremely satisfactory to
be working with you.
Strategy Head of Major Tech
Company
 
Oscilloscope Probe Market - Global Industry
Analysis, Size, Share, Growth, Trends And
Forecast
$4200
Vaccines Storage Equipment Market – Global
Industry Analysis, Size, Share, Growth, Trends
and Forecast
$4200
Veterinary Point of Care Blood Gas Analyzers
Market – Global Industry Analysis, Size,
Share, Growth, Trends and Forecast
$4200
Nitinol-based Medical Device Market –
Global Industry Analysis, Size, Share, Growth,
Trends and Forecast
$4200
Related Reports
Some other reports from this category!
B
0
C
E

2. QUICK LINKS
About Us
Faq
Press Release
My account
Blog
Contact Us
How to order
Refund and Cancellation
Become A Reseller
POPULAR CATEGORIES
Aerospace & Defense
Consumer Goods
Energy & Power
Healthcare
ICT, Semiconductor & Electronics
Materials & Chemicals
CONTACTS
1st Floor, Kalpavruksha O ce No 1,
GK Lane Number 3, Ingawale Nagar,
Pimple Nilakh, Pune, Maharashtra
411027

+1 909 414 1393

sales@growthmarketreports.com

KEEP IN TOUCH
CONNECT WITH US
WE ACCEPT
Your email 
Terms and conditions | Privacy | Growth Market Reports is Product of YOAAP Media Services LLP.
Home  Medical Devices & Supplies  Antipsychotic Drugs Market - Global Industry Analysis, Size, Share, Growth , Trends, and Forecast 2021 - 2028
An psycho c Drugs Market
Global Industry Analysis,
Size, Share, Growth , Trends,
and Forecast 2021 - 2028
Antipsychotic Drugs Market by Drugs Class (First Generation [Haldo, Navane,
and Others], Second Generation [Invega, Latuda, Seroquel, Risperdal,
Zyprexa, Geodon, and Others], Third Generation [Abilify]), Applications
(Schizophrenia, Bipolar Disorders, Dementia, Unipolar Depression, and
Others), and Regions (Asia Paci c, North America, Latin America, Europe,
and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size,
Trends, and Forecast 2021 – 2028.
Report ID: HC-2319
Author: Growth Market Reports
Rating: 4.9
Total Reviews: 3
No. Of Pages: 194
Format:  
Pub. Date: Upcoming
Share:   
Report Description Table Of Content Segments Competitive Landscape Methodology
The global antipsychotic drug market size is expected to expand at a considerable CAGR during the forecast period, 2021–2028. The
growth of the market is attributed to the increase in incidences of psychotic disorders such as hallucinations, schizophrenia, bipolar
disorder, delusions, and severe depression.
2018
H
2019
H
2020
A
2021
P
2022
P
2023
P
2024
P
2025
P
2026
P
2027
P
2028
P
-
200.0
400.0
600.0
800.0
1,000.0
1,200.0
1,400.0
1,600.0
1,800.0
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
XXXXX
XXXXX
XX%
XX% XX%
XX%
XX% XX%
XX%
XX%
XX%
XX%
Market Value Y-o-Y Growth
2020 2021 2022 2023 2024 2025 2026 2027 2028
XXXXX
XXXXX
XX
XX
XX
XX
XX
XX
XX
Market Value Abolute $ Opportunity
An psycho c Drugs Market Size (USD Million), Forecast
and Y-o-Y Growth, 2018-2028
An psycho c Drugs Market ,Absolute $ Opportunity, in
USD Million, 2020-2028
• Le Figure represents Antipsychotic Drugs Market size and forecast from 2018 to 2028; wherein 2018, 2019 are historic years, 2020 is the
base/actual year and forecast is provided from 2021 to 2028. The market is expected to grow at year-on-year growth rate of XX% between
2019 and 2020 owing to Covid-19 situa on and slowdown in the economic ac vi es.
• Right Figure represents the absolute $ opportunity between 2020 to 2028 in Antipsychotic Drugs Market . It indicates the availability of
poten al revenue generation opportunity for each year. The overall incremental opportunity between 2020 and 2028 is expected to be
valued at USD XX Mn.
Key Takeaways
Source: Growth Market Reports Analysis Source: Growth Market Reports Analysis
Antipsychotic drugs, also known as neuroleptics tranquilizers, are predominantly used for the treatment of psychosis and psychotic
diseases such as delusions, hallucinations, schizophrenia, bipolar disorder and others. Schizophrenia is considered to be the most
common and major psychotic disorder, which has a large number of patients across the globe. As per a study by the Anxiety and
Depression Association of America, anxiety is the most common mental illness in the US, around 40 million cases in the country were
recorded for the group of age 18 and above, or 18.1% of the population per year. Approximately one-half of the total number of
patients identi ed with depression are also detected with an anxiety disorder. The World Health Organization (WHO) has suggested
about the formulation of mental health action plan to prevent mental disorders and encourage mental health globally. Furthermore, as
per the statistics by WHO, an about 300 million people are suffering from depression whereas 60 million cases are diagnosed with
bipolar disorder globally. Children and adults are at high risk of psychiatric illnesses. It is estimated that nearly 44 million American
adults suffer from the ill-effects of uneasiness issue.
The COVID-19 pandemic caused several hardship in the global economy, due to the lockdowns and restriction imposed by the
governments across the globe. The pandemic had caused negative impact on the market due to large disruption in the production of
the drugs and delayed the non-COVID-19 emergency services. However, with the reduced number of the COVID-19 cases, the market
has regained its revenue due to wide resumption of the business operations worldwide.
Market Trends, Drivers, Restraints, and Opportunities
Heavy investments from key drugs manufacturing organizations for the development of effective drug as well as governments’
initiative to increase the awareness regarding the disorders among the population are driving the market in the near future.
Change in daily habits, increased consumption of drugs and alcohol, as well as rising stress life are key reasons for increasing
the mental issues among a large number of the global population. This is expected to drive the market growth.
Expansion of R&D activities and rapid introduction of novel antipsychotic compounds are bolstering the market growth.
Adverse effects such as blurred vision, insomnia, drowsiness, dry mouth, and probability of habit formation are proved to be
harmful for the patient’s health. These factors are hampering the market development in the coming years.
Rising patent terminations of key brands such as Risperdal, Seroquel, Invega, and Zyprexa, are restricting the market growth.
The presence of huge pool of geriatric population who are at high risk of psychosis and rising healthcare awareness are
projected to create huge opportunities for the market expansion during the forecast period.
Scope of the Report
The report on the global antipsychotic drugs market includes an assessment of the market, trends, segments, and regional markets.
Overview and dynamics have also been included in the report.
Attributes Details
Report Title Antipsychotic Drugs Market - Global
Industry Analysis, Growth, Share, Size,
Trends, and Forecast
Base Year 2020
Historic Data 2018–2019
Forecast Period 2021–2028
Segmentation Drugs Class (First Generation [Haldo,
Navane, and Others], Second Generation
[Invega, Latuda, Seroquel, Risperdal,
Zyprexa, Geodon, and Others], Third
Generation [Abilify]), and Applications
(Schizophrenia, Bipolar Disorders,
Dementia, Unipolar Depression, and
Others)
Regional Scope Asia Paci c, North America, Latin
America, Europe, and Middle East &
Africa
Report Coverage Company Share, Market Analysis and
Size, Competitive Landscape, Growth
Factors, and Trends, and Revenue
Forecast
Key Players Covered in the Report Johnson & Johnson; P zer, Inc.; Eli Lilly &
Co.; Bristol-Myers Squibb; AstraZeneca;
Glaxo SmithKline, Plc; and Allergan, Inc.
Market Segment Insights
Second generation segment is expected to grow at a rapid pace
Based on drugs class, the global antipsychotic drugs market is divided into rst generation, second generation, and third generation.
The rst generation segment is further classi ed into navane, haldo, and others. The second generation segment is segmented into
geodon, invega, latuda, zyprexa, seroquel, risperdal, and others while the third generation consists of abilify. The second generation
segment is expected to grow at a rapid pace attributed to the high e cacy of the drugs and are more advanced products than the
rst generation antipsychotics. This class is named as atypical antipsychotics includes sertindole, clozapine, asenapne, paliperidone,
olanzapine, risperidone, quetiapine. Meanwhile, the third generation segment is projected to account for a key market share since the
drugs are widely used for the maintenance therapy of the disease. Moreover, the drugs generation offer several bene ts such as
better tolerability and safety, which is contributing to the growth of the segment during the projected period.
An psycho c Drugs Market Basis Point Share (BPS) Analysis, by type
Source: Growth Market Reports Analysis
2021 2028
XX% XX%
XX% XX%
First Genera on Second Genera on Third Genera on
XX
XX
XX
Schizophrenia segment is projected to expand at a considerable CAGR
On the basis of applications, the market is segregated into schizophrenia, bipolar disorders, dementia, unipolar depression, and
others. The schizophrenia segment is projected to expand at a considerable CAGR owing to the high number of cases across the
world. Additionally, improved diagnostics & treatment and high awareness among the population is contributing for the fast growth
rate in the near future. Meanwhile, the unipolar disorder segment is anticipated to ourish remarkably in the near future due to the
easy diagnosis and increased awareness among the people. Moreover, the wide prevalence of the disorder globally is likely to drive the
segment growth.
North America is anticipated to constitute a key market share
In terms of regions, the global antipsychotic drugs market is classi ed as Asia Paci c, North America, Latin America, Europe, and
Middle East & Africa. North America is anticipated to constitute a key market share during the projected period as the region records
high number of mental illness patients. As per the report of Anxiety and Depression Association of America in year 2016,
approximately 6.7% population of the U.S. with age 18 years and more was suffering from major depression. Such high prevalence of
the disorder and improved healthcare services system in the region is anticipated to push the overall market growth.
Growth Poten al
CAGR
2020
-
27
Asia Pacific, XX
Middle East & Africa,
XX
North America, XX
La n America, XX
Europe, XX
Source: Growth Market Reports Analysis
An psycho c Drugs Market A rac veness Analysis by Regions
The Asia Paci c market, however, is estimated to grow at a signi cant rate in the coming years due to large number of the disorder
cases, developing healthcare facilities, and developing new drug approvals in the region. Additionally, the increasing awareness
among the population is also a key factor for the market growth in the region.
Customize This Report
Ask for Research To Be Focused On
Speci c Regions or Segments
Receive Data As Per Your Format and
De nition
Companies Pro led based on Your
Requirements
Breaking Down Competitive
Landscape as per Your Requirements
Any Level of Customization
Our Clients
Client Testinomials
Get in Touch with Us
 +1 909 414 1393
 sales@growthmarketreports.com
Buy Report
Single User $4200 
Multi User $5200 
Corporate User $6600 
Online License $2999 
Excel Data Pack $2599 
Add to Cart
REQUEST FOR SAMPLE
ENQUIRY BEFORE BUYING
SPEAK WITH ANALYST
REQUEST FOR CUSTOMIZATION
 
We needed a highly accurate and
precise report, which Growth Market
Reports delivered promptly. The
company compiled information from a
wide array of reliable agencies and
sourcess.It is extremely satisfactory to
be working with you.
Strategy Head of Major Tech
Company
 
Oscilloscope Probe Market - Global Industry
Analysis, Size, Share, Growth, Trends And
Forecast
$4200
Vaccines Storage Equipment Market – Global
Industry Analysis, Size, Share, Growth, Trends
and Forecast
$4200
Veterinary Point of Care Blood Gas Analyzers
Market – Global Industry Analysis, Size,
Share, Growth, Trends and Forecast
$4200
Nitinol-based Medical Device Market –
Global Industry Analysis, Size, Share, Growth,
Trends and Forecast
$4200
Related Reports
Some other reports from this category!
B
0
C
E